Stock GYRE GYRE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Gyre Therapeutics, Inc.

Equities

GYRE

US4037831033

End-of-day quote Nasdaq
Other stock markets
 18:00:00 2024-05-22 EDT 		5-day change 1st Jan Change
12.61 USD -6.87% Intraday chart for Gyre Therapeutics, Inc. -11.45% -50.91%
05-09 Gyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-03 Gyre Therapeutics Insider Sold Shares Worth $323,000, According to a Recent SEC Filing MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Gyre Therapeutics Insider Sold Shares Worth $323,000, According to a Recent SEC Filing
MT
Gyre Therapeutics Announces Appointment of Rodney L. Nussbaum to the Board of Directors and Member of Audit Committee
CI
Gyre Therapeutics, Inc. Announces Board Changes
CI
Gyre Therapeutics, Inc. Announces CEO Changes, Effective January 15, 2024
CI
Gyre Therapeutics, Inc. and Beijing Continent Pharmaceuticals Co., Ltd. Announce the Resignation of Charles Wu as Member of the Board of Directors. Effective on January 15, 2024
CI
Gyre Therapeutics, Inc. Announces Management Changes
CI
Gyre Therapeutics, Inc. Announces Management Changes
CI
Gyre Therapeutics, Inc. Announces CEO Changes
CI
Gyre Therapeutics, Inc. Announces Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GYRE Stock
  4. News Gyre Therapeutics, Inc.
  5. Insiders